PB 105 of 2022
National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 7)
I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 28 October 2022
NIKOLAI TSYGANOV
Acting Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name........................................................................................................................................ 1
2 Commencement........................................................................................................................ 1
3 Authority.................................................................................................................................. 1
4 Schedules................................................................................................................................. 1
Schedule 1—Amendments 2
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 7).
This instrument may also be cited as PB 105 of 2022.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information |
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 November 2022 | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
1. Schedule 1- entry for Piroxicam
Omit
| Piroxicam | Dispersible tablet 20 mg | Oral | Feldene‑D | 25 | 4.45 | 11.89 |
2. Schedule 1, entry for Roxithromycin
Omit
| Roxithromycin | Tablet 150 mg | Oral | Rulide | 10 | 2.81 | 4.95 |
| | Tablet 300 mg | Oral | Rulide | 5 | 2.81 | 4.95 |
Substitute
| Roxithromycin | Tablet 150 mg | Oral | Rulide | 10 | 2.81 | 4.95 |
3. Schedule 1, entry for Salbutamol
Omit
| Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | | Inhalation | Ventolin Nebules | 1 | 2.98 | 4.54 |
| | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 | | Inhalation | Asmol 2.5 uni‑dose | 1 | 3.72 | 3.95 |
| | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | | Inhalation | Ventolin Nebules | 1 | 3.11 | 4.66 |
| | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 | | Inhalation | Asmol 5 uni‑dose | 1 | 3.92 | 4.15 |
| | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | | Inhalation by mouth | Asmol CFC‑Free with dose counter | 1 | 4.92 | 6.82 |
| | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | | Inhalation by mouth | Ventolin CFC‑Free with dose counter | 1 | 4.92 | 6.82 |
Substitute
| Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 2.98 | 4.54 |
| | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 3.11 | 4.66 |
| | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth | Asmol CFC‑Free with dose counter | 1 | 4.92 | 6.82 |
| | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth | Ventolin CFC‑Free with dose counter | 1 | 4.92 | 6.82 |